Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 3 recruiting now full pipeline small index

Esophageal Squamous Cell Carcinoma (ESCC): full-pipeline trial registry

3 of 6 indexed Esophageal Squamous Cell Carcinoma (ESCC) trials are currently recruiting.

Corpus placement: #2,866 of 28,707 conditions by registered trial count.

Jump to open trials → Trial finder

6 US clinical trials · 3 currently recruiting · #2,866 of 28,707 conditions by registered trial count

Esophageal Squamous Cell Carcinoma (ESCC): 6 US clinical trials tracked, 3 recruiting.

Esophageal Squamous Cell Carcinoma (ESCC) is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is BeiGene, running 2 of these trials.

Enrollment posture brief

Registry condition esophageal-squamous-cell-carcinoma-escc

OPEN 3 | RECR 50% | LATE 3 | EARLY 2 | RANK #2866 | SPON 2

Volume-matched condition peers

Nearest open-share peer: Achalasia (50% recruiting · 8 trials)

Acute Hypoxemic Respiratory 66.7%Abdominal Aortic Aneurysms50%Acupuncture50%Acute Lymphoblastic Leukemia50%Esophageal Squamous Cell (th…50%
Open-enrollment share among volume-matched conditions near Esophageal Squamous Cell Carcinoma (ESCC)

Esophageal Squamous Cell Carcinoma (ESCC) lists 3 open slots (50% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Esophageal Squamous Cell Carcinoma (ESCC) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Esophageal Squamous Cell Carcinoma (ESCC) is recruiting above its size-band peers.

    3 of 6 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Esophageal Squamous Cell Carcinoma (ESCC) research.

    BeiGene accounts for 2 of 6 trials (33.3%). 5 distinct sponsors appear on at least one study for this condition label.

  3. Typical Esophageal Squamous Cell Carcinoma (ESCC) enrolment sits around 649 participants.

    Median target enrolment is 649 among the 6 trials that report a genuine target (sentinel values excluded). 1 of those (16.7%) plan for fewer than 100 participants.

  4. Esophageal Squamous Cell Carcinoma (ESCC) research is mostly interventional.

    5 interventional and 1 observational studies make up this index (83.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 12Phase 33

Phase Distribution

PhaseTrial count
Phase 1 2
Phase 3 3

Top Sponsors

BeiGene 2 trials
Radiopharm Theranostics 1 trials
ALX Oncology 1 trials
City of Hope Medical Center 1 trials
Merck Sharp & Dohme 1 trials

Named interventions

Most-linked intervention names on Esophageal Squamous Cell Carcinoma (ESCC) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Paclitaxel Drug
2 trials
radiotherapy Radiation
1 trials
ALX2004 Drug
1 trials
Fluorouracil (5-FU) Drug
1 trials
177Lu-BetaBart Drug
1 trials
cisplatin Drug
1 trials
5-FU Drug
1 trials
Irinotecan Drug
1 trials

US sites by state

Facility locations filed on Esophageal Squamous Cell Carcinoma (ESCC) trials. A trial with sites in several states counts in each.

Michigan 4 trials
Washington 2 trials
Utah 2 trials
Texas 2 trials
Oregon 2 trials
California 2 trials
Wisconsin 1 trials
Virginia 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Esophageal Squamous Cell Carcinoma (ESCC) page

6 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 3 Esophageal Squamous Cell Carcinoma (ESCC) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • BeiGene sponsors the most Esophageal Squamous Cell Carcinoma (ESCC) trials on record, review their full trial history before evaluating a specific study. See BeiGene's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Esophageal Squamous Cell Carcinoma (ESCC) condition card totals 6 registered trials; most-linked intervention Paclitaxel; top US site state Michigan. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.